Evaluation of mint efficacy regarding dysmenorrhea in comparison with mefenamic acid: A double blinded randomized crossover study

Seyedeh Zahra Masoumi, Horieh Rezvani Asl, Jalal Poorolajal, Mohammad Hosseini Panah, Seyedeh Reyhaneh Oliaei



Background: Menthol is the most important active material in mint and different mechanisms have been suggested for the way mint functions, most of which emphasize its analgesic effect owing to the presence of a group of temporary protein receptors. This study investigates the efficacy of peppermint capsule in the treatment of primary dysmenorrhea, in comparison with Mefenamic
Acid and placebo.

Materials and Methods: This was a prospective, double-blinded, crossover study and was conducted on 127 girl students studying in Hamadan University of Medical Sciences who had experienced primary dysmenorrhea. Each participant was asked to take one of the drugs including Mefenamic Acid and Mint, starting from the first menstruation for 3 days. At the end of each period, a questionnaire was used to gather information; through the volunteer herself, pain intensity was recorded according to visual analog scale (VAS), duration of pain according to COX questionnaire, and bleeding amount according to pictorial blood loss assessment chart (PBAC) chart (Hygham).

Results: Average pain intensity and duration of pain were significantly lower after intake of Mefenamic Acid and Mint (P < 0.05). Average bleeding was significantly lower in those taking Mefenamic Acid capsule than in those taking peppermint extract (P < 0.05). Nausea and diarrhea were lower in the mint group than in Mefenamic Acid group. But analgesic usage was lower in Mefenamic Acid group than in peppermint group (P < 0.05).

Conclusions: While the bleeding amount did not significantly change, pain and its severity and all the clinical signs and symptoms decreased after taking peppermint extract. Because the side effect of herbal drugs is lower than other medicinal drugs, using mint is advised for treating dysmenorrhea symptoms.

Key words: Crossover study, dysmenorrhea, Iran, Mefenamic Acid, mint


Crossover study; dysmenorrhea;Iran; Mefenamic Acid; mint

Full Text:



Berek J, Novak E. Berek and Novak’s Gynecology. 14th ed. Tehran: Gholban Arianteb; 2007. p. 481-6.

Ryan K, Berkowitz R, Barbieri R. Kistner’s Gynecology and Women’s Health. 7th ed. USA: Mosby; 1999. p. 45-6.

Gagua T, Tkeshelashvili B, Gagua D. Primary dysmenorrhea: Prevalence in adolescent population of Tbilisi, Georgia and risk factors. J Turk Ger Gynecol Assoc 2012;13:162-8.

Grandi G, Ferrari S, Xholli A, Cannoletta M, Palma F, Romani C, et al. Prevalence of menstrual pain in young women: What is dysmenorrhea? J Pain Res 2012;5:169-74.

Khodakarami B, Masoumi SZ, Faradmal J, Nazari M, Saadati M, Sharifi F, et al. The severity of dysmenorrhea and its relationship with body mass index among female adolescents in Hamadan, Iran. J Midwifery Reproductive Health 2015;3:444-50.

Murphy Goodwin T, Montoro MN, Muderspach L, Paulson R. Management of Common Problems in Obstetrics and Gynecology. 5th ed. North America: Wiley-Blackwell; 2010. p. 97-100.

Fletcher HM, Dawkins J, Rattray C, Wharfe G, Reid M, Gordon-Strachan G. Morinda citrifolia (Noni) as an anti-inflammatory treatment in women with primary dysmenorrhoea: A randomised double-blind placebo-controlled trial. Obstet Gynecol Int 2013;2013:195454.

Alves JG, de Brito Rde C, Cavalcanti TS. Effectiveness of Menthapiperita in the treatment of infantile colic: A crossover stud. Evid Based Complement Alternat Med 2012;2012:981352.

Jalilzadeh-Amin G, Mahama M. Evaluation of pulegone on transit time and castor-oil induced diarrhea in rat. Pharmaceutical Sci 2013;19:77-82.

Hiki N, Kaminishi M, Hasunuma T, Nakamura M, Nomura S, Yahagi N, et al. A phase I study evaluating tolerability, pharmacokinetics, and preliminary efficacy of L-menthol in upper gastrointestinal endoscopy. Clin Pharmacol Ther 2011;90:221-8.

Taher YA. Antinociceptive activity of Mentha piperita leaf aqueous extract in mice. Libyan J Med 2012;7.

Kligler M, Chadhary S. Peppermint oil. Am Fam Physician 2007;75:1028-30.

Mills S, Bone K. Principles and Parctice of Phytotherapy: Modern Herbal Medicine. 2nd ed. London: Churchill Livingstone; 2013. p. 1-110.

Somerville KW, Richmond CR, Bill GD. Delayed release peppermint oil capsules (Colpermin) for the spastic colon syndrome: A pharmacokinetic study. Br J Clin Pharmacol 1984;18:638-40.

Kooshk A, Tofighiyan T, Rakhshani MH. Comparison of the effects of marine omega-3 fatty acids and ibuprofen on primary dysmenorrehea. Life Sci J 2013;10:1-3.

Hoaglin DC, Filonenko A, Glickman ME, Wasiak R, Gidwani R. Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding. Eur J Med Res 2013;18:17.

Wasner G, Schattschneider J, Binder A, Baron R. Topical menthol-a human model for cold pain by activation and sensitization of C nociceptors. Brain 2004;127:1159-71.

Kline RM, Kline JJ, Di Palma J, Barbero GJ. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr 2001;138:125-8.

French L. Dysmenorrhea in adolescents: Diagnosis and treatment. Paediatr Drugs 2008;10:1-7.

Khodakrami N, Moatar F, Ghahiri A. Comparison of the effect of an herbal drug (SCA) and mefenamic acid on primary dysmenorrhoea a clinical control trial. Horizon Med Sci 2008;14:11-9.

Asif M. Study of anthranylic acid derivatives: Mefenamic acid and its various analogues. Am J Med Studies 2014;2:24-30.

Taylor T. Treatment of nausea and vomiting in pregnancy. Aust Prescr 2014;37:42-5.

Shavakh A, Ardestani SK, Taki M, Goli M, Kashteli AH. Premedication with Peppermint oil capsules in colonoscopy: A double blind placebo-controlled randomazed trial study. Acta Gastroenterol Belg 2012;75:349-53.

Cappelo G, Spezzaferro M, Grossi L, Manzoli L. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: A prospective double blind placebo-controlled randomized trial. Dig Liver Dis 2007;39:530-6.


  • There are currently no refbacks.